Showing results (171-180 of 244) with videos related to
Sort By:
Pageof 25
Angewandte Chemie (International Ed. in English)|September 9, 2014
Dissecting ubiquitin signaling with linkage-defined and protease resistant ubiquitin chainsTatjana Schneider, Daniel Schneider, Daniel Rösner, et al.Chemical Communications (Cambridge, England)|August 5, 2014
Efficient labelling of enzymatically synthesized vinyl-modified DNA by an inverse-electron-demand Diels-Alder reactionHolger Busskamp, Ellen Batroff, Andrea Niederwieser, et al.Nucleic Acids Research|March 27, 2023
A dual-purpose polymerase engineered for direct sequencing of pseudouridine and queuosineLuisa B Huber, Navpreet Kaur, Melanie Henkel, et al.International Journal of Cancer|October 16, 2012
RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinomaPierre Tennstedt, Robert Fresow, Ronald Simon, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 5, 2013
Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagusMichael F Nentwich, Katharina von Loga, Matthias Reeh, et al.Scientific Data|February 5, 2025
BioVars - A bioclimatic dataset for Europe based on a large regional climate ensemble for periods in 1971-2098Anne Reichmuth, Oldrich Rakovec, Friedrich Boeing, et al.Pathology Oncology Research : POR|June 1, 2015
Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue MicroarraysPhillip R Stahl, Jessica Schnellert, Christina Koop, et al.Biorxiv : the Preprint Server for Biology|July 9, 2025
The IFN I response in tumor cells is shaped by PARP7-p300/CBP interactions through distinct loss- and gain-of-function mechanismsIvan Rodriguez Siordia, Sonja Rieth, Rory Morgan, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 21, 2020
Insights into Praziquantel Metabolism and Potential Enantiomeric Cytochrome P450-Mediated Drug-Drug InteractionGloria Vendrell-Navarro, Holger Scheible, Floriane Lignet, et al.Blood|December 14, 2002
Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AMLThomas Kindler, Frank Breitenbuecher, Andreas Marx, et al.Pageof 25